C-Myc inhibitor 6
C-Myc inhibitor 6 (compound A102) is a c-Myc inhibitor. c-Myc inhibitor 6 decreases cancer cell viability and degrades c-Myc protein. c-Myc inhibitor 6 can be used for the research of c-Myc imbalance, such as cancer, cardiovascular diseases, and viral infection[1].
Product Specifications
CAS Number
[2768765-58-6]
UNSPSC
12352005
Target
C-Myc
Type
Reference compound
Related Pathways
Apoptosis
Applications
COVID-19-anti-virus
Field of Research
Cancer; Infection; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/c-myc-inhibitor-6.html
Purity
98.04
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC(C)C[C@@H](B(O)O)NC(CCNC(OCC1C2=CC=CC=C2C3=CC=CC=C31)=O)=O
Molecular Formula
C23H29BN2O5
Molecular Weight
424.30
References & Citations
[1]Tong, Youzhi, et al. C-myc protein inhibitor, preparation method therefor, and use thereof. WO2022089556. 2021.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Browse additional items from our catalog
Nuclear cap-binding protein subunit 1 (NCBP1) Chicken ELISA Kit
Papilloma Virus, Human, Type 18, E6 (hPV, Human Papillomavirus Type 18 E6, E6, Early Protein E6, HpV18gp1, Protein E6) (MaxLight 650)
Papilloma Virus, Human, Type 18, E6 (hPV, Human Papillomavirus Type 18 E6, E6, Early Protein E6, HpV18gp1, Protein E6) (MaxLight 650)
